1 Min Read
April 11 (Reuters) - ContraVir Pharmaceuticals Inc
* ContraVir Pharma- TXL has completed phase 1 clinical trial in healthy volunteers, showing favorable safety, tolerability, drug distribution profile Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.